Debt AdvisoryHealthcareSIGNED
WallachBeth Capital Closes $4 Million Registered Direct Financing for bioAffinity Technologies
Value
$4M
Target
bioAffinity Technologies
WallachBeth Capital LLC announced the closing of a $4 million registered direct financing of common stock for bioAffinity Technologies, Inc. The financing was priced at-the-market under Nasdaq rules.
✦ Meridian Analysis
This is a direct financing transaction for a US-based biotechnology company, facilitated by WallachBeth Capital. It represents a capital raise for the company to support its operations.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.